Sector Intelligence · HCIT · June 2026
HCIT Investment 2026
Healthcare information technology market data, NHS digital transformation investment, EHR platforms, AI analytics and private capital opportunities in health IT — for investors and family offices.
Market Data
The Numbers Shaping HCIT in 2026
$13.0bn
UK healthcare IT market size in 2025, projected to reach $25.8 billion by 2034 at a CAGR of 7.70%.
Source: IMARC Group 2026
$386.6bn
Global healthcare IT market value in 2026, projected to reach $961.3 billion by 2030 at a 14.9% CAGR.
Source: Towards Healthcare April 2026
60.5%
Share of UK digital health expenditure in 2025 accounted for by hospitals and NHS trusts — the dominant end-user segment.
Source: Mordor Intelligence 2026
19.8%
Projected CAGR of healthcare analytics and AI within UK digital health through 2031 — the fastest-growing technology segment.
Source: Mordor Intelligence 2026
Investment Landscape
The HCIT Market in 2026
Healthcare information technology is one of the largest and fastest-growing segments in global healthcare private equity. Provider and biopharma remain the largest healthcare PE market segments, driven by healthcare IT activity. The market encompasses electronic health records, telehealth platforms, clinical decision support, revenue cycle management, population health management, healthcare analytics and AI-enabled clinical tools.
The healthcare IT market in the UK is witnessing rapid growth driven by increasing digital transformation initiatives, rising demand for telemedicine and growing investments in healthcare infrastructure modernisation. Healthcare IT solutions such as EHRs, telehealth platforms, healthcare analytics and cloud-based systems are becoming increasingly essential for improving patient care, operational efficiency and healthcare accessibility.
In the UK specifically, the NHS 10-Year Plan and the government's commitment to creating a digital-first health service are generating sustained public sector demand for HCIT infrastructure — with private capital benefiting through vendor relationships, NHS procurement frameworks and adjacent private healthcare digitisation.
What Investors Are Targeting
Assets Attracting Capital in HCIT
EHR and Clinical Platform Roll-Up
The fragmentation of the UK healthcare back-office is a significant arbitrage opportunity, with private equity expected to be the most active buyer in the sub-$50 million bracket. Clinical administration platforms, workforce management systems and revenue cycle management businesses are prime consolidation targets.
AI Analytics and Population Health
AI-powered analytics and predictive healthcare tools are improving clinical decision-making, diagnostics and patient management. Population health platforms with NHS data partnerships, predictive readmission tools and ambient clinical intelligence — AI that documents clinical encounters in real time — are attracting growth capital.
Telehealth and Remote Monitoring
Tele-healthcare led the UK digital health market with 35.12% revenue share in 2025. Virtual ward platforms, remote patient monitoring tools and chronic disease management applications — particularly those with established NHS deployment — command strong valuations from both strategic and financial buyers.
Key Risks
Risks for HCIT Investors in 2026
- NHS procurement complexity creates long sales cycles and revenue unpredictability for HCIT vendors
- Cybersecurity risk: criminals are using AI to launch more sophisticated attacks on interconnected health systems
- Interoperability standards and NHS data infrastructure gaps slowing platform adoption
- MHRA Software as a Medical Device classification for AI clinical tools adding regulatory cost
Subscribe
Stay Informed on Healthcare Investment
Subscribe to Healthcare Investor Magazine — independent investment intelligence for investors, family offices and private wealth owners.
FAQs
Frequently Asked Questions
Related Sectors
Explore Other Investment Sectors
Published for informational purposes only. Does not constitute financial or investment advice. All data sourced from primary institutional sources as cited. Seek independent professional advice before making any investment decision.